Bluejay Diagnostics, Inc.
BJDX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001704287
In the last 90 days, Bluejay Diagnostics, Inc. insiders filed 1 open-market purchase and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $259.3K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Bluejay Diagnostics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 11 | 6 | −5 |
| Shares | 178.7K | 22.9K | −155.8K (−87.2%) |
| Value | $47.4K | $99.8K | +$52.4K (+110.6%) |
New holders (2)
Institutions that held Bluejay Diagnostics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 21,221 | $91.9K | 0.29% |
| JPMorgan Chase & Co | 211 | $914 | 0.00% |
Sold out (7)
Institutions that held Bluejay Diagnostics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Renaissance Technologies LLC | 49,100 | $13.0K |
| HRT Financial LP | 29,907 | $8.00K |
| Geode Capital Management, LLC | 29,139 | $7.86K |
| Two Sigma Securities, LLC | 27,094 | $7.12K |
| Vanguard Group Inc | 15,899 | $4.18K |
| Northern Trust Corp | 11,699 | $3.08K |
| UBS Group AG | 5,158 | $1.36K |